Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Global patient registry to monitor long-term safety and effectiveness of Increlex in children and adolescents with severe primary insulin-like growth factor-1 deficiency (SPIGFD)
A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia
Benefit: Tightens skin, reduces wrinkles, and boosts radiance
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study
Additional risk factors are detailed in the Company's periodic filings with the SEC, including those listed in the "Risk Factors" section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q
US$ 27.32
.webp)
US$ 28.92
US$ 23.02
US$ 21.71
US$ 26.70
US$ 23.76
US$ 28.84
